Clinical trial
A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
NCT01874600 is registered in ClinicalTrials.gov with Brain Sentinel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
- Lead sponsor
- Brain Sentinel
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2013
- Completion date
- December 31, 2019
- Enrollment
- 239 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.